Sign Up for Free!

Continue Analyzing the page and more.

Continue with Google

Already have an Account? Log In

The Trial has ended

Continue Analyzing the page and more.

Upgrade to Pro
Home Dashboard
    • Plans Blog Contact
    Ticker Image

    US$0

    US$32.2m

    -2.0%

    46.8%

    Overview Price History News Competitors Earnings per Share Return on Equity Net Margin Share Buyback Leverage Financial Ratio
    Dashboard Funda..tals Deep..lue Prediction Screener Map

    Intensity Therapeutics Inc Overview

    Industry: Biotechnology

    Sector: Healthcare

    Read More

    Intensity Therapeutics Inc is evaluated based on the investment philosophy and approach to stock market investing developed by renowned investor Warren Buffett. Companies with high ratings typically exhibit growing earnings, a substantial profit margin, conservative leverage, a consistently high return on equity, and a sustained practice of repurchasing their shares over the years.

    Intensity Therapeutics Inc

    Score

    Recent News



    Earnings Per Share

    Score 0.00/5
    Intensity Therapeutics Inc earns a low score, as its Earnings Per Share (EPS) has not shown continuous growth over the last six years. Notable counterparts in the sector with high scores includes Zoetis Inc UnitedHealth Group Incorporated IQVIA Holdings Inc
    In Biotechnology industry , Vertex Pharmaceuticals Inc , Halozyme Therapeutics Inc , Corcept Therapeutics Incorporated are companies with high ratings.

    Return on Equity

    Score 3.75/5
    Intensity Therapeutics Inc stands out with a superior score in the Return on Equity (ROE) section, surpassing the sector median value and showcasing its strong performance in this metric. The top companies in the same sector include Zoetis Inc UnitedHealth Group Incorporated IQVIA Holdings Inc

    0% 10.0% 20.0% 30.0% 40.0%

    ROE

    Company 0%

    SP500 Industry 0%

    0% 10.0% 20.0% 30.0% 40.0%

    ROE

    Company 0%

    SP500 Industry 0%

    0% 10.0% 20.0% 30.0% 40.0%

    ROE

    Company 0%

    SP500 Industry 0%

    0% 10.0% 20.0% 30.0% 40.0%

    ROE

    Company 0%

    SP500 Industry 0%

    In Biotechnology industry , Vertex Pharmaceuticals Inc , Halozyme Therapeutics Inc , Corcept Therapeutics Incorporated are companies with high ratings.

    0% 10.0% 20.0% 30.0% 40.0%

    ROE

    Company 0%

    SP500 Industry 0%

    0% 10.0% 20.0% 30.0% 40.0%

    ROE

    Company 0%

    SP500 Industry 0%

    0% 10.0% 20.0% 30.0% 40.0%

    ROE

    Company 0%

    SP500 Industry 0%

    0% 10.0% 20.0% 30.0% 40.0%

    ROE

    Company 0%

    SP500 Industry 0%

    Net Margin

    Score 4.20/5
    Intensity Therapeutics Inc commands a high score, propelled by its net margin consistently outpacing the sector median value and exhibiting continuous growth in recent six years; noteworthy counterparts in the sector, boasting similarly high scores, include Zoetis Inc UnitedHealth Group Incorporated IQVIA Holdings Inc

    0% 10.0% 20.0% 30.0% 40.0%

    Net Margin

    Company 0%

    SP500 Industry 0%

    0% 10.0% 20.0% 30.0% 40.0%

    Net Margin

    Company 0%

    SP500 Industry 0%

    0% 10.0% 20.0% 30.0% 40.0%

    Net Margin

    Company 0%

    SP500 Industry 0%

    0% 10.0% 20.0% 30.0% 40.0%

    Net Margin

    Company 0%

    SP500 Industry 0%

    In Biotechnology industry , Vertex Pharmaceuticals Inc , Halozyme Therapeutics Inc , Corcept Therapeutics Incorporated are companies with high ratings.

    0% 10.0% 20.0% 30.0% 40.0%

    Net Margin

    Company 0%

    SP500 Industry 0%

    0% 10.0% 20.0% 30.0% 40.0%

    Net Margin

    Company 0%

    SP500 Industry 0%

    0% 10.0% 20.0% 30.0% 40.0%

    Net Margin

    Company 0%

    SP500 Industry 0%

    0% 10.0% 20.0% 30.0% 40.0%

    Net Margin

    Company 0%

    SP500 Industry 0%

    Share Buyback

    In Biotechnology industry , Vertex Pharmaceuticals Inc , Halozyme Therapeutics Inc , Corcept Therapeutics Incorporated are companies with high ratings.

    Leverage

    Score 4.97/5
    Intensity Therapeutics Inc attains a commendable score in the category due to its lower leverage ratio over the past six years in comparison to the sector median value. Additionally, other notable companies in the same sector, such as Zoetis Inc UnitedHealth Group Incorporated IQVIA Holdings Inc , also exhibit high scores.

    0    10.0    20.0    30.0    40.0   

    Leverage

    Company 0

    SP500 Industry 0

    0    10.0    20.0    30.0    40.0   

    Leverage

    Company 0

    SP500 Industry 0

    0    10.0    20.0    30.0    40.0   

    Leverage

    Company 0

    SP500 Industry 0

    0    10.0    20.0    30.0    40.0   

    Leverage

    Company 0

    SP500 Industry 0

    In Biotechnology industry , Vertex Pharmaceuticals Inc , Halozyme Therapeutics Inc , Corcept Therapeutics Incorporated are companies with high ratings.

    0    10.0    20.0    30.0    40.0   

    Leverage

    Company 0

    SP500 Industry 0

    0    10.0    20.0    30.0    40.0   

    Leverage

    Company 0

    SP500 Industry 0

    0    10.0    20.0    30.0    40.0   

    Leverage

    Company 0

    SP500 Industry 0

    0    10.0    20.0    30.0    40.0   

    Leverage

    Company 0

    SP500 Industry 0

    Financial Ratio

    Yearly Quarterly

    Financial
    Profitability
    Growth
    Cash Flow
    Financial Health
    Efficiency Ratios

    Ticker Image

    Intensity Therapeutics Inc

    US$0

    US$32.2m

    -2.0%

    46.8%